Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?

JACC Cardiovasc Interv. 2011 Oct;4(10):1129-32. doi: 10.1016/j.jcin.2011.08.003.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Coronary Restenosis / prevention & control*
  • Drug-Eluting Stents / adverse effects*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • Thienopyridines / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • Thienopyridines
  • zotarolimus
  • Sirolimus